From Dallas, Texas, James Dondero is the co-founder and president of Highland Capital Management (HCM). He is currently overseeing the operations and strategies of the firm. He has over three decades of experience in credit market including being a pioneer of the Collateralized Loan Obligation (CLO). Due to his extemporary achievement, the firm has received numerous awards throughout his career including the hefty Morningstar’s 5-star designation for Global allocation in 2014. Other awards include being ranked number one by Morningstar on Healthcare for both long and short Equity Fund in 2014 and the Lipper Award for Floating Rate Opportunities in 2014.
James Dondero is an educated man who graduated from the University of Virginia and majored in accounting and finance. Jim is a Certified Management Accountant (CMA), a level that has made him earn the right to use Chartered Financial Analyst (CFA) designation. Apart from managing Highland Capital Management, James is engaged in other activities such as MGM Studios and American Banknote. He chairs boards of CCS Medical Corporation, Nexbank and Cornerstone Healthcare.
Recently, his company filed its quarterly 13F that revealed the portfolio of $3.42 billion. This was however a decrease of $1.49 billion from the previous quarter because it recorded a high value of $4.91 billion the recent filling, therefore, represents a 22.73% of its assets amounting to $15.04 billion under management by the company. Various decisions were made and which may have led to the recent value. For instance, the company made decisions to fund new purchases in this quarter. The new positions include Amazon Com Inc (AMZN) for $23.35 million, Spdr S&P 500 Etf Tr (Call) (SPY) for $67.07 million, Intra Cellular Therapies Inc (ITCI) for $15.90 million, and Eagle Pharmaceuticals Inc (EgRX) for $17.73 million among others.
Highland Capital Management has increased its stakes for Petterson Companies Inc (PDCO) by 16% equivalent to $87.91 million, and Salesforce Com Inc (Call) (CRM) by 18% equivalent to $54.85 million among others. However, HCM sold stocks for Spdr Series Trust constituting 5.63%, Envision Healthcare Holdings, Nexpoint CR Strategies and Laboratory Corp America Holdings. The reasons for selling the stocks are still unknown, but they have obviously had something to do with the momentum of the HCM, value and the drive to put the company in a better place. The top holdings of the enterprise currently remain to be Salesforce Com Inc (CRM), American Airls Group Inc (Call) (AAL) and Ishares Tr (Put) (IMW) constituting 13.59% of the listed securities.